Electrical stimulation therapy for muscle loss
Part of Brain & nervous system clinical trials.
This trial tests if a neuromuscular electrical stimulation therapy helps people with sarcopenia (muscle loss). It may improve muscle strength and function.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with muscle loss (sarcopenia) by a doctor using standard criteria.
- You are able to do an exercise program and follow instructions.
- You can understand the study and agree to join voluntarily.
- You can use a mobile phone, with or without help from a caregiver.
- You do not have certain medical conditions like recent knee surgery, a pacemaker, or severe leg circulation problems.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if whole-body electrical muscle stimulation exercise helps improve nerve signals to muscles in older adults. It compares older participants (65+) with younger ones (18-39) to see how this type of exercise affects muscle activation.
This study tests if physical therapy can help older adults with low muscle strength and mass (sarcopenia). It might improve your ability to do daily activities.
This trial tests a digital device to help people with sarcopenia (age-related muscle loss) build strength through a guided exercise program on a mobile phone.
This trial tests a remote rehabilitation program for people with sarcopenia (age-related muscle loss). It uses video calls and a smartphone app to help improve strength and mobility from home.
This study looks at muscle changes in people with or at risk for sarcopenia (age-related muscle loss). It aims to find better ways to detect and manage sarcopenia using simple tests like muscle strength and body composition measurements.
This trial tests a combined exercise and nutrition program to help older adults with sarcopenia (muscle loss). It aims to improve muscle strength and function, especially for those with metabolic syndrome.
Hear when a new Sarcopenia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.